YF476
01-023
Phase 1 small_molecule completed
Quick answer
YF476 for Hypergastrinaemia is a Phase 1 program (small_molecule) at Black Diamond Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Black Diamond Therapeutics
- Indication
- Hypergastrinaemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed